Thompson Brands’ Adora supplement arrives at retail
MERIDEN, Conn. Thompson Brands on Wednesday launched its Adora calcium and vitamin D supplement, an all-natural chocolate that is 30 calories per serving.
"After a great deal of research, we have perfected the formula for a delicious-tasting calcium and vitamin D supplement that is made from all-natural premium chocolate," stated Gene Dunkin, CEO of Thompson Brands. "This was not an easy task, considering the delicate balance between the calcium mineral’s inherent chalkiness, the recommended daily dosage in each serving size and the creamy texture and rich flavor we were trying to achieve."
Each chocolate Adora disk provides up to 50% of the daily value of calcium plus vitamin D3 and magnesium for optimal absorption. Adora calcium and vitamin D supplement is available in milk chocolate and dark chocolate flavors and can be found nationally at CVS/pharmacy stores, Whole Foods and other retailers for a suggested retail price of $9.99.
Report: San Francisco’s tobacco sales ban to expand to in-store pharmacies
SAN FRANCISCO A ban on tobacco sales in San Francisco drug stores soon will grow to include any store that operates a pharmacy, according to published reports.
The San Francisco Chronicle reported Monday that the city would extend its ban to supermarkets and mass merchandisers with pharmacies in addition to drug stores.
In 2008, retail pharmacies and the National Association of Chain Drug Stores opposed the ban because while banning tobacco products in drug stores, the city continued to permit supermarkets and mass merchandisers with pharmacies to sell tobacco products, prompting Walgreens to sue the city over the ban and try to have it overturned on constitutional grounds. City officials reasoned that the exception for drug stores was necessary because of what they described as the contradictory nature of a healthcare establishment selling a harmful product.
Soon after the San Francisco ban passed, Boston enacted a similar law, though the Boston law –– which was made independent of the one in San Francisco –– covered all retailers that operate pharmacies.
NACDS to FDA advisory committee: Curb DXM abuse without impeding appropriate use
ALEXANDRIA, Va. As the Food and Drug Administration’s Drug Safety and Risk Management Committee debated Tuesday on ways to curb abuse of cough suppressants containing dextromethorphan, the National Association of Chain Drug Stores testified that the scheduling of dextromethorphan under the federal Controlled Substances Act is not the right solution.
“Dextromethorphan is consumers’ No.1 choice to treat cough. Depriving consumers of the option to self-medicate with dextromethorphan would have substantial public health consequences because cough and cold are extremely prevalent in the U.S. population, affecting the average adult two to four times per year,” NACDS VP regulatory affairs Kevin Nicholson said to the FDA Drug Safety and Risk Management Committee.
NACDS also urged the committee to consider the approach set forth by Sen. Dick Durbin, D-Ill., in the Dextromethorphan Abuse Reduction Act of 2009, which would prohibit the sale of dextromethorphan to minors.
“Dextromethorphan is the most common ingredient in over-the-counter cough medicines in the United States,” Nicholson stated. “[The] abuse of dextromethorphan is concentrated primarily among teenagers, and this concentration makes possible a targeted and strategic approach to preventing abuse.”
In addition to working on legislative remedies, the association also has worked with the White House Office of National Drug Control Policy and the Drug Enforcement Administration to help raise awareness of the scourge of medication abuse, particularly among young people.